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In Brief
Nguyen et al. describe oocyte-specific functions for the three Aurora protein kinases during meiosis. The authors show, for the first time, negative interkinase regulation between the family members to control the localized activity of one another and that these interactions are critical for spindle integrity and gamete euploidy.
RESULTS AND DISCUSSION

Generation and Fertility Assessment of Mice Lacking AURKB and AURKC in Oocytes
Because of the lack of specificity of Aurora kinase B (AURKB) inhibitors and compensation of AURKB for loss of AURKC in oocytes, distinguishing the roles of these kinases is challenging. Prior approaches used overexpression and dominant negatives to investigate AURKB/C roles in mouse oocytes [5] [6] [7] [8] [9] [10] . Existing evidence supports unique AURKC roles, but the AURKB contributions during oocyte meiosis are unknown. We took a genetic approach to investigate the non-overlapping roles of AURKB/C in oocytes. We crossed an Aurkc knockout (Aurkc KO) mouse strain [7, 11] with a strain that lacked Aurkb (Aurkb cKO) [5] specifically in oocytes using Gdf9-mediated Cre excision (double-KO; Aurkb cKO/Aurkc KO). Real-time qPCR confirmed that Aurkb and Aurkc transcripts fell to background levels (Figures S1A and S1B). Western blotting using a phospho-specific AURK antibody that detects the activated kinase forms confirmed their absence (Figures S1C and S1D). The relative abundance of the AURKs in mouse oocytes has not previously been defined. Assuming that the phospho-specific antibody has similar affinities for each kinase and that each kinase is phosphorylated to a similar extent, we found that pAURKA was the most abundant; pAURKC expression was $2/3 of pAURKA and pAURKB was the lowest in wild-type (WT) oocytes (Figures S1C and S1D). Although the levels of pAURKA increased in double-KO oocytes (Figures S1C and S1D), total protein levels, as indicated by western blot analysis, did not change (Figures S1E and S1F), suggesting that, in the absence of AURKB/C, more AURKA can be activated.
To determine the consequence of deleting AURKB/C alone or in combination, we conducted fertility trials. Compared to WT, Aurkb cKO females were less fertile, and three of the five Aurkb cKO females failed to produce 6 litters, suggesting a premature decline in fertility ( Figure 1A) . These mice were significantly less fertile than Aurkc KOs [7] , indicating different requirements for these kinases for fecundity and that AURKB and AURKC compensation is not reciprocal. Because a catalytic component of the chromosomal passenger complex (CPC) is essential for its function and the CPC is required to complete meiosis I (MI) [10] , it was surprising that double-KO animals were not infertile (Figure 1A) . Although only AURKB/C have documented CPC function in oocytes in vivo, the fertility of double-KO females suggests another kinase compensates.
Active CPC Localizes to Chromosomes in the Absence of AURKB/C To confirm that the CPC localizes to chromosomes in double-KO oocytes, we assessed the localization of survivin, the CPC chromosome docking subunit. The localization of survivin did not change compared to WT in metaphase I (Met I) oocytes ( Figures  S2A and S2B ). Next, to determine whether the CPC was active, we evaluated the phosphorylation of CPC substrates INCENP, HEC1/Ndc80, and histone H3 [12] and found that their phosphorylation in double-KO oocytes was comparable to WT ( Figures  S2C-S2H ). Therefore, the localization and function of the CPC is normal in double-KO oocytes, despite the absence of the canonical kinase subunit.
AURKA Compensates for Loss of AURKB/C in an INCENP-Dependent Manner
The surprising normal CPC function in double-KO oocytes suggests compensation. In WT oocytes, AURKA localized to spindle poles. In contrast, in double-KO oocytes, AURKA localized to spindle poles and chromosomes ( Figures 1B-1G ). This chromosome localization of AURKA is similar to AURKC localization in WT oocytes and to AURKB localization in Aurkc KO oocytes [6, 7] , suggesting that it is recruited to chromosomes via the CPC. To determine whether this AURKA localization depends on INCENP, the CPC scaffold, we depleted INCENP in double-KO oocytes. Oocytes injected with INCENP morpholino oligonucleotides lost chromosomal-localized AURKA while retaining polar AURKA ( Figures 1E-1G ). These data indicate that chromosomal AURKA depends on INCENP in the absence of AURKB/C.
To determine whether the CPC is active in an AURKA-dependent manner, we treated oocytes with an AURKA-specific inhibitor, MLN8237 [13] . In WT oocytes, where AURKA was polar, INCENP was phosphorylated (pINCENP) at AURK-specific phosphorylation sites and pHEC1 levels did not change ( Figures  1H, 1I , and S3) [14] . In contrast, double-KO oocytes treated with MLN8237 lost pINCENP and pHEC1, indicating that this phosphorylation was dependent upon AURKA activity. Consistent with the requirement of AURKA in regulating meiotic maturation [15] , WT and double-KO oocytes treated with MLN8237 failed to extrude polar bodies and reach metaphase II (Met II) ( Figures 1K  and 1L ).
Further confirming the absence of AURKB/C, double-KO oocytes treated with ZM447439, an AURKB/C-specific inhibitor, retained pINCENP and pHEC1 levels ( Figures 1H, 1I , and S3). These oocytes were phenotypically unaffected ( Figures 1H-1L ). ZM447439 is an ATP-binding pocket inhibitor that does not interfere with binding of AURKB/C to the CPC [16, 17] . Therefore, phosphorylation of INCENP in double-KO oocytes, but not drug-treated WT, suggests the presence of AURKB/C prevents AURKA from binding to and compensating in the CPC. These data are consistent with a dependency on AURKA for CPC activity in double-KO oocytes.
AURKA Compensation Is Meiosis Specific
AURKA compensation for loss of AURKB/C in mouse oocytes is in contrast to findings in mitotic cells in which AURKB has been depleted by RNAi [5, 18] . However, a minor population of AURKB may keep AURKA from localizing to chromosomes. Because this is the first documentation of AURKA compensation in the CPC in vivo, we tested whether this mechanism is specific to meiotic cells using a knockout approach. We deleted AURKB in HeLa cells using an inducible Cas9 endonuclease and AURKB guide RNAs [19] . AURKB was absent from chromosomes upon Cas9 induction, and loss of AURKB caused abnormal metaphase figures ( Figure S4 ) [5] . Despite the loss of AURKB, we did not detect a chromosome-associated population of AURKA at metaphase ( Figure S4F ). In addition, INCENP was not phosphorylated and H3S10 phosphorylation was markedly reduced, suggesting that there is not a compensatory CPC-bound kinase (Figures S4C, S4D, S4G, and S4H). The inability of AURKA to compensate for AURKB deletion in mitosis suggests an oocyte-specific compensation mechanism. 
AURKC Prevents AURKA Chromosome Localization via INCENP Competition
AURK function is defined by localization, which is dictated by binding TPX2 or INCENP [18] . Because AURKA binds INCENP in vitro [20, 21] and AURKA chromosomal localization is INCENP dependent in oocytes ( Figures 1E-1G) , it is possible that competition for INCENP binding promotes AURKA's TPX2-associated function in oocytes. We assessed AURKA localization in oocytes harboring various copy numbers of Aurkb and Aurkc. AURKA localized to spindle poles in oocytes that expressed AURKC. In contrast, oocytes that lacked AURKC displayed chromosomal AURKA ( These findings suggest that AURKC outcompetes AURKA for CPC binding, consistent with AURKB/C having a higher affinity for INCENP [20] . To test this, we microinjected Aurkc-Gfp into WT and double-KO oocytes and assessed AURKA Met I localization. Similar to WT, where AURKC is CPC bound, overexpression of AURKC-GFP prevented AURKA from localizing to chromosomes in double-KOs ( Figures 2G and 2H ). This competition was not dependent on the activity of AURKC ( Figures 2G and  2H ). Finally, we found that, when AURKB was overexpressed, it also prevented AURKA chromosome localization ( Figures 2G  and 2H ). These data indicate that, in WT oocytes, where AURKC is more abundant that AURKB, AURKC is the primary AURK preventing AURKA from localizing to chromosomes.
CPC Competition Is Essential for Spindle Length and Meiotic Progression
Although double-KO mice retained fertility, these mice were less fertile than WT ( Figure 1A ). To determine whether this reproductive disadvantage was due to failing to keep AURKA at spindle poles, we analyzed the oocytes in vitro. The majority of WT oocytes (91.9% ± 2.81%) completed MI, but only 43.32% ± 10.58% of double-KO oocytes did ( Figures 1J-1L , 3A, and 3B). Compared to WT, double-KO oocytes had significantly shorter spindles ( Figures 3C and 3D ), and they frequently contained a pole-associated bivalent ( Figures 3E and 3F ). Using live-cell imaging, we observed that these pole-associated bivalents failed to disjoin (n = 8/18) and oocytes with short spindles arrested at Met I (Figures 3E and 3F; Videos S1, S2, S3, and S4). Although AURKA alone can support meiotic progression in vivo, there is a reduction in oocyte quality that reduces fertility.
The short spindle phenotype ( Figures 3C and 3D ) is similar to depletion of Aurka in oocytes [15] and when AURKA-TPX2 interaction is perturbed in mitosis [22] . Conversely, overexpression of AURKA causes elongated spindles in oocytes [15] . We hypothesized that competition of AURKC for INCENP ensures sufficient pole-localized AURKA to achieve a robust meiotic spindle length. We overexpressed either Aurka or Aurkc in double-KO oocytes and examined spindle length and meiotic progression. Although overexpression of Aurka-Gfp lengthened the spindles in double-KOs ( Figures 3G and 3H ), overexpression Aurkc-Gfp produced spindles more closely resembling WT ( Figures 3G  and 3H ). Completion of MI was rescued by overexpression of Aurka-Gfp or Aurkc-Gfp ( Figures 3I and 3J ). Importantly, although AURKA overexpression partially rescued these phenotypes, only when Aurkc-Gfp was introduced were the phenotypes fully resolved. Therefore, AURKC likely ensures sufficient polar AURKA for full fecundity. Alternatively, AURKA/AURKCspecific targets on chromosomes or at poles may regulate spindle length.
AURKB Is Required to Negatively Regulate AURKC Aurkb cKO females were significantly less fertile than Aurkc KO and WT ( Figure 1A ), suggesting that non-overlapping requirements exist. We observed an increase in the active form of AURKC upon Aurkb deletion (Figures S1C and S1D). Because the dosage of AURKC is important for completion of oocyte meiosis [10] , we evaluated fertilization-competent Met-II-arrested eggs. pAURKC levels increased on chromosomes in eggs isolated from Aurkb cKOs ( Figures 4A and 4B ). These levels were reduced to near WT levels when one copy of Aurkc was deleted in this genetic background (Aurkb cKO/Aurkc Het). Consistent with an increase in pAURKC, levels of pINCENP increased in Aurkb cKO eggs, and the levels were partially rescued in Aurkb cKO/Aurkc Hets ( Figures 4C and 4D ). These data suggest that AURKB is a negative regulator of AURKC.
To assess the phenotypic consequences of excess pAURKC, we evaluated the fertility of Aurkb cKO/Aurkc Het animals and observed partial rescue ( Figure 4E ). To determine how excess pAURKC reduces egg quality, we next analyzed chromosome numbers in Met-II-arrested eggs [23] . Compared to eggs from WT and Aurkc KOs, significantly more Aurkb cKO eggs were aneuploid, exhibiting both hyper-and hypo-ploidy ( Figures 4F-4H ). Aneuploidy was partially rescued in Aurkb cKO/Aurkc Hets (Figures 4F-4H) . Aurkb cKO eggs also displayed prematurely separated sister chromatids (PSSCs), which were reduced in Aurkb cKO/Aurkc Het eggs ( Figure 4I) . These phenotypes are similar to embryos overexpressing AURKC [10, 24] but differ from those in which AURKC is overexpressed in oocytes [10] . The presence of AURKB and/or AURKC overexpression could account for these disparities.
Studies suggest that an age-related decline in the meiosisspecific cohesin subunit REC8 causes PSSCs in mice and humans [25] [26] [27] . REC8 levels were unperturbed at Met I in Aurkb cKOs, suggesting that loading and stability were normal [26] ( Figures 4J and 4K) . Importantly, analyses of Met II chromatids revealed a significant decrease in centromeric REC8, which was rescued in Aurkb cKO/Aurkc Hets ( Figures 4L and 4M) . Therefore, the loss of sister chromatid cohesion occurs after anaphase I onset. Centromeric cohesion of sisters is protected by SGO2 via MPS1-dependent recruitment during MI so that sister chromatids co-segregate [28] . Reduction in SGO2 by 50% causes PSSCs in oocytes upon MPS1 inhibition [29] . To determine whether SGO2 was perturbed in Aurkb cKOs, we evaluated its levels at Met I and found a reduction of $60% compared to WT ( Figures 4N and 4O) . Importantly, this reduction was partially restored in oocytes from Aurkb cKO/Aurkc Hets (Figures 4N and  4O ). This partial rescue suggests separate AURKB and AURKC functions. Because inhibition of AURKB/C with ZM447439 modestly reduces MPS1 localization and subsequently SGO2 localization, it is possible that the role for AURKB is indirect, with the loss of AURKB affecting MPS1 [29] . Alternatively, this SGO2 defect could reflect a role of AURKB in promoting the translocation of SGO2 from chromosome arms to centromeres [30, 31] . Because SGO2 is reduced, and AURKC activity is increased, a possible non-overlapping AURKC pathway could involve triggering cleavage of centromeric REC8 that is no longer protected at anaphase I onset [32] . This role is consistent with the premature loss of cohesin in oocytes that have excess active AURKC due to overexpression of haspin [33] . These possibilities must be explored to understand the precise mechanisms of these two kinases in cohesion regulation. Taken together, these data suggest that negative regulation of AURKC by AURKB is critical for ensuring gamete euploidy.
Our data support a model in which all three Aurora kinases are required in mouse oocytes. In addition to its direct roles in spindle regulation [10, 34, 35] , AURKC promotes AURKA spindle pole localization via competition to ensure a robust spindle and completion of meiosis. Additionally, oocytes require AURKB to ensure accurate chromosome segregation.
Although mammalian germ cells rely on three AURKs, organisms from other evolutionary clades rely on different homolog numbers for meiosis [2, 3] . Fungi express one AURK, whereas Drosophila and nematodes express two. The AURK homologs likely evolved from a common ancestor through gene duplication [2, 3] . AURKA is the most ancestral, and the order of appearance of AURKB and AURKC is unsettled [2, 3] . The current model is that an ancestral AURKB/C hybrid from reptiles, fish, and nonplacental mammals evolved from AURKA prior to AURKB and AURKC individualization in placental mammals [3] . Additional AURKs could provide an evolutionary benefit, such as specialized functions and compensatory mechanisms. Our data predict that, although AURKC expression may provide optimal CPC activity due to its inherent stability [7] and support proper spindle building through CPC-binding competition, its expression has required oocytes to retain AURKB expression to negatively regulate AURKC [10] . It will be of interest to determine whether AURKB has other non-overlapping functions.
Classically, AURK function is spatially distinct and determined by binding partner affinity [18] . AURK affinities can be swapped by mutation of an amino acid residue of AURKA or AURKB, allowing compensation for each other's loss, indicating that their substrate specificities are similar [20, 36] . We demonstrated that, in mouse oocytes, this localization is less stringent than in somatic cells because AURKA localized to chromosomes in oocytes in vivo upon deletion of Aurkc, suggesting that an oocytespecific factor allows this localization. It is possible that we are unable to detect minor populations of AURKA-CPC that exist in HeLa cells [21, 37, 38] . Alternatively, a mechanism may prevent AURKA chromosome localization in mitotic cells. Strikingly, pups were born to double-KO mothers, suggesting that AURKA Figure S1 and Videos S1, S2, S3, and S4. compensation exists in the first mitotic divisions of preimplantation embryos before zygotic expression of Aurkb. Alternatively, the CPC may not be essential for early embryonic mitoses because INCENP and survivin knockout embryos develop to the 8-cell stage before failing [39, 40] . These INCENP and survivin KO findings could help explain the high level of aneuploidies that give rise to mosaic embryos in humans [41] .
AURKB and AURKC mutations can cause human infertility [42, 43] , highlighting their diagnostic importance in assisted reproduction. Aberrant AURKC expression also drives tumorigenesis and invasiveness in many cancer cell lines [44, 45] . Identification of the mechanism by which AURKB restricts AURKC could provide insights into how AURKC activity could be inhibited and assist in designing precision medicine approaches for patients with an AURKC-positive expression signature.
STAR+METHODS
Detailed methods are provided in the online version of this paper and include the following: 
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The authors declare no competing interests. Figure 1A . Note that the control and single-KO data are from animals presented in Figure 1A , as these trials were conducted simultaneously. n = 3-5 mice/genotype. For induced ovulation and collection of metaphase II eggs, female mice (6-8 wks. age) were injected with 5 I.U. of PMSG followed by 5 I.U. of equine choronic gonadotropin (eCG) (Sigma-Aldrich) 48h later. Sixteen hours post eCG injection, cumulous-enclosed egg complexes were collected from the oviduct and cultured in hyaluronidase (3 mg/ml, Sigma) in MEM for 5 min. Denuded eggs were then washed free of hyaluronidase and allowed to recover for 5 min prior to fixation. ML8237 (Alisertib; Selleckchem), Monastrol (Sigma), and ZM447439 (Tocris) were dissolved in dimethyl sulfoxide (DMSO) (Sigma) and added to the CZB culture media at a final concentration of 40 mM, 100 mM, and 5 mM respectively. In vitro maturation of drug-treated oocytes was performed in organ culture dishes (Becton Dickinson) under humidified conditions. Morpholino oligonucleotides specific for INCENP were designed and produced by Genetools as previously described [10, 34] . Morpholino sequences are INCENP 5 0 -CGTCTTCCCGGACCACTCCTTTTCC-3 0 and scrambled control, 5 0 -GCGCCCCCGC CGTTTCAAAGACAAA-3 0 . All morpholinos were injected at a concentration of 100 mM. INCENP knockdown reduces the phospho-INCENP signal by $50% [34, 50] .
Constructs and cRNA generation
Generation of Aurka, Aurkc, Aurkb, and Aurkc-KD constructs were previously described [6, 9, 47] . Aurka and Aurkc were PCR amplified from a C57BL/6 12.5d embryo cDNA library and cloned into pIVT-GFP. Mutagenesis was performed using a site-directed Mutagenesis kit per manufacturer's instructions (Agilent, QuikChange II site-directed mutagenesis kit). mEGFP-Cdk5rap2 cRNA was produced from a pGEMHE vector containing mouse full-length Cdk5rap2 (NM_145990.4) N-terminally fused to EGFP (a gift from Dr. Tomoya Kitajima, RIKEN). To generate cRNA, plasmids were linearized with Nde I, purified (QIAGEN, QIAquick PCR Purification), and in vitro transcribed using an mMessage mMachine T7 kit (Ambion), according to manufacturer's protocol. The synthesized cRNAs were then purified using an RNAeasy kit (QIAGEN) and stored at À 80 C. All cRNAs were injected at 500 ng/mL.
Real-Time PCR
Twenty prophase-I arrested oocytes were collected and frozen before processing. Gfp mRNA (2 ng) was added to all samples and used as the reference gene. Total RNA for each mixture was purified using the Picopure RNA isolation kit (Thermo Fisher) per the manufacturer's protocol. cDNA was generated by reverse transcription utilizing random hexamers and SuperScript II (Thermo Fisher). Expression levels of the Aurks were measured by quantitative real-time PCR analysis acquired using an ABI Prism 7000 (Life Technologies) according to the manufacturer's instructions. Taqman probes specific for Aurkb, and Aurkc (MM01718140_m1, and MM03039426_g1, respectively, Life Technologies, Grand Island, NY) were used for gene expression detection and the comparative C t method was used to determine the difference in expression between samples [49] .
Western blotting
A total of 100 prophase-I arrested oocytes,100 Met II eggs, or 20 mg HeLa DNA were mixed with SDS sample buffer (1% SDS, 1% b-mercaptoethanol, 20% glycerol, 50 mM Tris-HCl (pH 6.8)), and denatured at 95 C for 10 min. Western blotting was performed as previously described [50] followed by incubation of the membrane overnight with primary antibodies. The membranes were incubated with horseradish peroxidase-conjugated secondary antibodies GE Healthcare Biosciences, #NA931) for 1 h. Protein bands were detected using the ECL Select western blotting detection reagents (Amersham) following the manufacturer's protocol.
Immunocytochemistry
Following meiotic maturation, oocytes were fixed in PBS-containing paraformaldehyde (PFA: Sigma) at room temperature (ACA and pINCENP: 2% PFA for 20 mins; Survivin, pAURKA; pHEC1, pAURKC, REC8, and SGO2: 2% PFA + 0.1% Triton-X for 20 mins; TPX2: 3.7% PFA 1 h) or 100% methanol at À20 C (AURKA: 10 min) followed by 2 consecutive washes through blocking buffer (PBS + 0.3% (wt/vol) BSA + 0.1% (vol/vol) Tween-20). Prior to immunostaining, oocytes were permeabilized for 20 min in PBS containing 0.1% (vol/vol) Triton X-100 and 0.3% (wt/vol) BSA followed by 10 min in blocking buffer. Immunostaining was performed by incubating cells in primary antibody for 1 h at room temperature followed by 3 consecutive 10 min incubations in blocking buffer. After washing, secondary antibodies were diluted 1:200 in blocking solution and the sample was incubated for 1 h at room temperature followed by 3 consecutive 10 min incubations in blocking buffer. The cells were next mounted in VectaShield (Vector Laboratories) with 4 0 , 6-Diamidino-2-Phenylindole, Dihydrochloride (DAPI; Life Technologies; 1:170).
For immunofluorescence of meiotic spreads, a clean microscope slide was dipped in Milli-Q water (pH 9.2) containing 1% PFA, 0.15%, Triton X-100 (Sigma), and 3 mM dithiothreitol (Sigma). Zona pellucida-free metaphase II eggs were pipetted along the length of the slide and dried. Prior to immunostaining, slides were washed with PBS followed by incubation in blocking solution (PBS + 3% BSA) for 10 min. Immunostaining was performed at room temperature by incubating slides in primary antibody diluted in blocking buffer for 3 h followed by 3 subsequent 10 min incubations in blocking buffer. After washes, slides were incubated in secondary antibodies diluted in blocking buffer for 1 h followed by 3 subsequent 10 min incubations in blocking buffer. Slides were mounted in Vectashield with DAPI.
For immunofluorescence of HeLa cell lines, on day 3 of doxycycline treatment, 150 X10 5 cells were plated in 6 well plates containing coated poly-L-Lysine coated coverslips and were fixed 24 h after plating with PBS containing 3.7% paraformaldehyde for 10 min at room temperature. After washing, cells were permeabilized using PBS-0.5% Triton X-100 for 10 min at room temperature and were subsequently blocked in PBS-1% Bovine Serum Albumin (Sigma) for 1 h at room temperature. Samples were then incubated primary antibody diluted in PBS-0.1% Triton X-100 for 1 hour in a humidified chamber at room temperature. Slides then were incubated in
